.png){kind=icon}
返回
TPP-based conjugates: potential targeting ligands
.png){kind=icon}
PRE
AI
DOI：10.1016/j.drudis.2024.103983.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Mitochondria are one of the major sources of energy as well as regulators of cancer cell metabolism. Thus, they are potential targets for the effective treatment and management of cancer. Research has explored triphenylphosphonium (TPP) derivatives as potent cancertargeting ligands because of their lipophilic nature and mitochondrial af finity. In this review, we summarize the utility of TPP-based conjugates targeting mitochondria in different types of cancer and other diseases, such as neurodegenerative and cardiovascular disorders. Such conjugates offer versatile therapeutic potential by modulating membrane potential, in fluencing reactive oxygen species (ROS) production, and coupling of molecular modi fications (such as ATP metabolism and energy metabolism). Thus, we highlight TPP conjugates as promising mitochondria -targeting agents for use in targeted drug delivery systems.
Keyword:
LUNG-CANCER
TRIPHENYLPHOSPHONIUM
APOPTOSIS
NANOPARTICLES
DELIVERY
CELLS
STRATEGIES
COMPLEXES
CHITOSAN
SYSTEM
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells.png)
FASEB JOURNAL
OAAI
FASEB JOURNALIF4.2
OAAI分享收藏The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium-Resveratrol Conjugate on Breast Cancer CellsPHARMACEUTICALSOAAI
PHARMACEUTICALSIF4.8
OAAI分享收藏
查看更多内容